COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,757 Articles (22,502 medRxiv, 8,255 bioRxiv)

Most recent first Previous |  Page 437: Articles 4361-4370  | Next

Underreporting of SARS-CoV-2 infections during the first wave of the 2020 COVID-19 epidemic in Finland - Bayesian inference based on a series of serological surveys
Nieminen, T. A., Auranen, K., Kulathinal, S., Harkanen, T., Melin, M., Palmu, A. A., Jokinen, J.
10.1101/2023.02.15.23285941 — Posted: 2023-02-16
On the Impact of Mass Screening for SARS-CoV-2 through Self-Testing in Greece
Gilmour, S., Sapounas, S., Drakopoulos, K., Jaillet, P., Magiorkinis, G., Trichakis, N.
10.1101/2023.02.15.23285963 — Posted: 2023-02-16
Quantification of early nonpharmaceutical interventions 1 aimed at slowing transmission of Coronavirus Disease 2019 in the Navajo Nation and surrounding states (Arizona, Colorado, New Mexico, and Utah)
Miller, E. F., Neumann, J., Chen, Y., Mallela, A., Lin, Y. T., Hlavacek, W. s., Posner, r. G.
10.1101/2023.02.15.23285971 — Posted: 2023-02-16
The role of wastewater-based epidemiology for SARS-CoV-2 in developing countries: cumulative evidence from South Africa supports sentinel site surveillance to guide public health decision-making
Iwu-Jaja, C. J., Ndlovu, N., Rachida, S., Yousif, M., Taukobong, S., Macheke, M., Mhlanga, L., Van Schalwyk, C., Pulliam, J., Moultrie, T., le Roux, W., Schaefer, L., Pocock, G., Coetzee, L., Mans, J., Bux, F., Pillay, L., de Villiers, D., du Toit, A., Jambo, D., Gomba, A., Groenink, S., Madgewick, N., van der Walt, M., Mutshembele, A., Berkowitz, N., Suchard, M., McCarthy, K.
10.1101/2023.02.13.23285226 — Posted: 2023-02-15
Characterizing the use of the ICD-10 Code for Long COVID in 3 US Healthcare Systems
Zhang, H. G., Honerlaw, J. P., Maripuri, M., Samayamuthu, M. J., Beaulieu-Jones, B. R., Baig, H. S., L'Yi, S., Ho, Y.-L., Morris, M., Panickan, V. A., Wang, X., Hong, C., Weber, G. M., Liao, K. P., Visweswaran, S., Tan, B. W. Q., Yuan, W., Gehlenborg, N., Muralidhar, S., Ramoni, R. B., The Consortium for Clinical Characterization of COVID-19 by EHR (4CE), , Kohane, I. S., Xia, Z., Cho, K., Cai, T., Brat, G. A.
10.1101/2023.02.12.23285701 — Posted: 2023-02-15
Development and characterization of a multimeric recombinant protein based on the spike protein receptor binding domain of SARS-CoV-2 that can neutralize virus infection
de Lima, V. A., Ferreira, R. d. S., Oliva, M. L. V., Andreata-Santos, R., Janini, L. M. R., Maricato, J. T., Akamatsu, M. A., Ho, P. L., Schenkman, S.
10.1101/2023.02.15.528632 — Posted: 2023-02-15
Sotrovimab retains activity against SARS-CoV-2 Omicron variant BQ.1.1 in a non-human primate model
Herate, C., Marlin, R., Touret, F., Bosquet, N. D., Donati, F., Relouzat, F., Junges, L., Galhaut, M., Dehan, O., Sconosciutti, Q., Nougairede, A., de Lamballerie, X., van der Werf, S., Le Grand, R.
10.1101/2023.02.15.528538 — Posted: 2023-02-15
Optimal Delivery Management for the Prevention of Early Neonatal SARS-CoV-2 Infection: Systematic review and Meta-analysis
Chan, C. S., Kong, J. Y., Sultana, R., Mundra, V., Babata, K., Mazzarella, K., Adhikari, E., Yeo, K. T., Hascoet, J.-M., Brion, L. P.
10.1101/2023.02.14.23285921 — Posted: 2023-02-15
Low Antibody Titers Demonstrate Significantly Increased Rate of SARS-CoV-2 Infection in a Highly Vaccinated Population from the National Basketball Association
Tai, C., Haviland, M. J., Kissler, S. M., Lucia, R. M., Merson, M., Maragakis, L. L., Ho, D. D., Anderson, D. J., DiFiori, J., Grubaugh, N. D., Grad, Y. H., Mack, C. D.
10.1101/2023.02.10.23285780 — Posted: 2023-02-14
Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older: analysis of nation-wide patient electronic health records in the United States
Gorenflo, M., Davis, p. B., Kaelber, D., Xu, R.
10.1101/2023.02.11.23285801 — Posted: 2023-02-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).